CAD 0.88
(-1.12%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -175.52 Million USD | 18.68% |
2022 | -215.84 Million USD | 27.28% |
2021 | -296.83 Million USD | -711.86% |
2020 | -36.56 Million USD | 44.01% |
2019 | -65.3 Million USD | -2211.28% |
2018 | 3.09 Million USD | 3723.73% |
2017 | -85.35 Thousand USD | 20.99% |
2016 | -108.03 Thousand USD | -328.03% |
2015 | 47.37 Thousand USD | 140.34% |
2014 | -117.43 Thousand USD | 42.07% |
2013 | -202.73 Thousand USD | 43.9% |
2012 | -361.38 Thousand USD | -880.2% |
2011 | -36.86 Thousand USD | 98.38% |
2010 | -2.27 Million USD | 21.81% |
2009 | -2.91 Million USD | -43.66% |
2008 | -2.02 Million USD | -246.6% |
2007 | -584.55 Thousand USD | 40.43% |
2006 | -981.23 Thousand USD | 28.19% |
2005 | -1.36 Million USD | -211.8% |
2004 | -438.24 Thousand USD | 0.16% |
2003 | -438.97 Thousand USD | -2868.38% |
2002 | -14.78 Thousand USD | -117.92% |
2001 | 82.52 Thousand USD | 117.07% |
2000 | -483.56 Thousand USD | -94.67% |
1999 | -248.4 Thousand USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -5.19 Million USD | -297.08% |
2024 Q2 | -54.33 Million USD | -946.25% |
2023 Q3 | -113.44 Million USD | -210.52% |
2023 Q4 | 2.63 Million USD | 102.32% |
2023 Q2 | -36.53 Million USD | -31.36% |
2023 FY | -175.52 Million USD | 18.68% |
2023 Q1 | -27.81 Million USD | 84.6% |
2022 Q2 | -8.29 Million USD | 64.96% |
2022 Q4 | -180.62 Million USD | -5459.34% |
2022 FY | -215.84 Million USD | 27.28% |
2022 Q1 | -23.67 Million USD | -98.77% |
2022 Q3 | -3.24 Million USD | 60.84% |
2021 Q3 | -270.64 Million USD | -5506.9% |
2021 Q4 | -11.91 Million USD | 95.6% |
2021 FY | -296.83 Million USD | -711.86% |
2021 Q1 | -29.39 Million USD | 38.99% |
2021 Q2 | -4.82 Million USD | 83.58% |
2020 Q4 | -48.18 Million USD | -545.93% |
2020 FY | -36.56 Million USD | 44.01% |
2020 Q2 | -18.89 Million USD | -155.75% |
2020 Q3 | -7.45 Million USD | 60.53% |
2020 Q1 | -7.38 Million USD | 73.6% |
2019 Q3 | -6.96 Million USD | -243.53% |
2019 FY | -65.3 Million USD | -2211.28% |
2019 Q2 | -2.02 Million USD | 67.46% |
2019 Q4 | -27.98 Million USD | -302.13% |
2019 Q1 | -6.22 Million USD | -35.25% |
2018 Q3 | -63.97 Thousand USD | -155.64% |
2018 Q1 | -20.77 Thousand USD | 50.65% |
2018 FY | 3.09 Million USD | 3723.73% |
2018 Q4 | -4.6 Million USD | -7096.01% |
2018 Q2 | 114.99 Thousand USD | 653.55% |
2017 FY | -85.35 Thousand USD | 20.99% |
2017 Q3 | -13.2 Thousand USD | 20.23% |
2017 Q2 | -16.55 Thousand USD | -26.03% |
2017 Q4 | -42.09 Thousand USD | -218.82% |
2017 Q1 | -13.13 Thousand USD | 80.67% |
2016 Q2 | -18.36 Thousand USD | -21.71% |
2016 Q3 | -8081.64 USD | 55.99% |
2016 Q4 | -67.95 Thousand USD | -740.82% |
2016 FY | -108.03 Thousand USD | -328.03% |
2016 Q1 | -15.08 Thousand USD | 32.36% |
2015 Q4 | -22.3 Thousand USD | -98.89% |
2015 FY | 47.37 Thousand USD | 140.34% |
2015 Q3 | -11.21 Thousand USD | -111.2% |
2015 Q2 | 100.18 Thousand USD | 590.52% |
2015 Q1 | -20.42 Thousand USD | 59.28% |
2014 Q3 | -30.08 Thousand USD | -15.13% |
2014 Q1 | -18.13 Thousand USD | 76.56% |
2014 FY | -117.43 Thousand USD | 42.07% |
2014 Q4 | -50.16 Thousand USD | -66.74% |
2014 Q2 | -26.13 Thousand USD | -44.08% |
2013 Q3 | -61.57 Thousand USD | -54.53% |
2013 Q2 | -39.84 Thousand USD | -56.34% |
2013 FY | -202.73 Thousand USD | 43.9% |
2013 Q1 | -25.48 Thousand USD | 76.79% |
2013 Q4 | -77.38 Thousand USD | -25.68% |
2012 FY | -361.38 Thousand USD | -880.2% |
2012 Q3 | -73.88 Thousand USD | -29.35% |
2012 Q2 | -57.11 Thousand USD | 53.45% |
2012 Q1 | -122.71 Thousand USD | -408.81% |
2012 Q4 | -109.82 Thousand USD | -48.65% |
2011 Q2 | 76.96 Thousand USD | 187.34% |
2011 Q1 | -88.12 Thousand USD | 95.67% |
2011 Q3 | -66.7 Thousand USD | -186.66% |
2011 Q4 | 39.73 Thousand USD | 159.57% |
2011 FY | -36.86 Thousand USD | 98.38% |
2010 Q3 | -59 Thousand USD | 39.11% |
2010 Q4 | -2.03 Million USD | -3350.94% |
2010 FY | -2.27 Million USD | 21.81% |
2010 Q2 | -96.9 Thousand USD | -15.25% |
2010 Q1 | -84.08 Thousand USD | 96.82% |
2009 Q3 | -57.96 Thousand USD | 56.84% |
2009 Q2 | -134.31 Thousand USD | -93.47% |
2009 Q1 | -69.42 Thousand USD | 81.37% |
2009 FY | -2.91 Million USD | -43.66% |
2009 Q4 | -2.64 Million USD | -4458.15% |
2008 FY | -2.02 Million USD | -246.6% |
2008 Q4 | -372.71 Thousand USD | 74.33% |
2008 Q2 | -34.63 Thousand USD | 83.01% |
2008 Q1 | -203.91 Thousand USD | -280.85% |
2008 Q3 | -1.45 Million USD | -4092.38% |
2007 FY | -584.55 Thousand USD | 40.43% |
2007 Q4 | 112.75 Thousand USD | 218.17% |
2007 Q3 | -95.41 Thousand USD | 78.63% |
2007 Q2 | -446.5 Thousand USD | -411.44% |
2007 Q1 | -87.3 Thousand USD | 85.11% |
2006 Q3 | -107.01 Thousand USD | 33.23% |
2006 Q4 | -586.2 Thousand USD | -447.79% |
2006 Q2 | -160.28 Thousand USD | -25.91% |
2006 FY | -981.23 Thousand USD | 28.19% |
2006 Q1 | -127.29 Thousand USD | -173.72% |
2005 Q3 | -1.27 Million USD | -1776.77% |
2005 Q4 | 172.67 Thousand USD | 113.59% |
2005 Q2 | -67.68 Thousand USD | 63.66% |
2005 Q1 | -186.25 Thousand USD | -2.24% |
2005 FY | -1.36 Million USD | -211.8% |
2004 FY | -438.24 Thousand USD | 0.16% |
2004 Q2 | -33.08 Thousand USD | 68.01% |
2004 Q4 | -182.17 Thousand USD | -76.18% |
2004 Q1 | -103.41 Thousand USD | 51.78% |
2004 Q3 | -103.4 Thousand USD | -212.52% |
2003 FY | -438.97 Thousand USD | -2868.38% |
2003 Q1 | -28.66 Thousand USD | 40.92% |
2003 Q2 | -24.38 Thousand USD | 14.92% |
2003 Q3 | -167.43 Thousand USD | -586.53% |
2003 Q4 | -214.46 Thousand USD | -28.09% |
2002 Q1 | -23.81 Thousand USD | 0.0% |
2002 FY | -14.78 Thousand USD | -117.92% |
2002 Q4 | -48.52 Thousand USD | -81.97% |
2002 Q3 | -26.66 Thousand USD | -132.12% |
2002 Q2 | 83.01 Thousand USD | 448.58% |
2001 FY | 82.52 Thousand USD | 117.07% |
2000 FY | -483.56 Thousand USD | -94.67% |
1999 FY | -248.4 Thousand USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Aion Therapeutic Inc. | -6.28 Million CAD | -2691.737% |
Ayurcann Holdings Corp. | -3.96 Million CAD | -4323.732% |
Blueberries Medical Corp. | -1.63 Million CAD | -10632.835% |
The BC Bud Corporation | -1.22 Million CAD | -14239.377% |
BioNxt Solutions Inc. | -7.72 Million CAD | -2172.739% |
CordovaCann Corp. | -6.88 Million CAD | -2449.462% |
Christina Lake Cannabis Corp. | -4.13 Million CAD | -4148.048% |
Captor Capital Corp. | -11.38 Million CAD | -1442.24% |
City View Green Holdings Inc. | -2.44 Million CAD | -7068.283% |
1CM Inc. | -913.85 Thousand CAD | -19106.725% |
Global Hemp Group Inc. | -2.58 Million CAD | -6701.768% |
Greenway Greenhouse Cannabis Corporation | -4.72 Million CAD | -3616.59% |
IM Cannabis Corp. | -9.49 Million CAD | -1747.989% |
Lobe Sciences Ltd. | -4.7 Million CAD | -3628.68% |
Maple Leaf Green World Inc. | -1.09 Million CAD | -15980.408% |
Mountain Valley MD Holdings Inc. | -7.67 Million CAD | -2188.422% |
Nextleaf Solutions Ltd. | 223.33 Thousand CAD | 78691.706% |
Ovation Science Inc. | -813.14 Thousand CAD | -21485.466% |
Pharmadrug Inc. | -13.2 Million CAD | -1229.579% |
Captiva Verde Wellness Corp. | -6.08 Million CAD | -2784.451% |
RAMM Pharma Corp. | -7.72 Million CAD | -2173.333% |
RIV Capital Inc. | -106.76 Million CAD | -64.408% |
Revive Therapeutics Ltd. | -5.61 Million CAD | -3023.933% |
Red White & Bloom Brands Inc. | -138.89 Million CAD | -26.367% |
SLANG Worldwide Inc. | -19.36 Million CAD | -806.327% |
1933 Industries Inc. | -13.36 Million CAD | -1213.402% |
Red Light Holland Corp. | -7.62 Million CAD | -2201.24% |
Top Strike Resources Corp. | -1.72 Million CAD | -10104.584% |
Xebra Brands Ltd. | -1.95 Million CAD | -8867.191% |
Adastra Holdings Ltd. | -3.54 Million CAD | -4851.755% |